Hyun Jeong Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hyun Jeong Lee has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- C. Hyung Keun Park
Department of Psychiatry, Asan Medical Center, Seoul, Republic of Korea
3 shared publications - Jeong Hun Yang
Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea
3 shared publications - Sang Jin Rhee
Seoul National University College of Medicine
3 shared publications - Yong Min Ahn
Seoul National University Hospital
3 shared publications - Dae Hun Kang
Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Korea
2 shared publications - Jieun Yoo
School of Social Welfare, Yonsei University, Yonsei University, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (33)
Changes in Mental Health Networks Among High-Risk Suicide Groups in Korea Before and After the COVID-19 Pandemic
Yang JH, et al. J Korean Med Sci. 2026 Aug;41:e216. https://doi.org/10.3346/jkms.2026.41.e216
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (33)
Open AccessChanges in Mental Health Networks Among High-Risk Suicide Groups in Korea Before and After the COVID-19 Pandemic
Yang JH, et al. J Korean Med Sci. 2026 Aug;41:e216. https://doi.org/10.3346/jkms.2026.41.e216
- Open Access
- 24 September 2025
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 13 (1) , e64846
Impact of a 24-Week Mobile App–Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort Study
Background: Overweight or obesity is a prognostic factor for breast cancer recurrence and breast cancer–related deaths. However, weight control is difficult for breast cancer survivors because of menopause, chemotherapy, antihormonal therapy, and psychological issues. Objective: This study aimed to develop a 24-week mobile app–based human coaching program using Noom and evaluate its efficacy in breast cancer survivors who are excessively overweight or with obesity, including those who successfully used the program. Methods: In this single-arm prospective cohort study, 130 breast cancer survivors with BMI ≥25 were enrolled and received a 24-week program, including diet-, exercise-, and psychology-based content with the trained human coach in Noom between 2019 and 2021. For a hyperactive group who joined for more than 16 weeks, we evaluated weight, BMI, lipid level, bioimpedance, and quality of life at baseline, 6-month, and 12-month follow-up. Results: Among 130 breast cancer survivors, 101 (77.7%) and 93 (71.5%) completed the 6-month and 12-month follow-ups, respectively. The mean age of all participants was 54.90 (SD 7.42) years. At baseline, the median BMI was 27.14 (IQR 25.20‐35.36) for the hyperactive group and 27.50 (IQR 25.20‐35.50) for the active and inactive group. In the hyperactive group (68/101, 67%), body weight and BMI significantly reduced (mean difference −1.97, 95% CI −2.65 to −1.26 kg; P<.01 and mean difference −0.86, 95% CI −1.15 to −0.56; P<.01, respectively) at 6 months and were maintained at 12 months without the yo-yo effect. Among the lipid panel, triglyceride levels decreased significantly (−34.13, 95% CI −58.09 to−10.17; P<.01) and were maintained at 12 months. With respect to bioimpedance components, skeletal muscle mass (kg), body fat mass (kg), percent body fat (%), waist-to-hip ratio, and visceral fat area (cm2) improved in the first 6 months. However, waist-to-hip ratio and visceral fat area increased during the next 6 months. Based on the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ C30) and Breast Cancer Module (23 items), nausea or vomiting, constipation, body image, and arm and breast symptoms significantly improved during the first 6 months. Conclusions: This study demonstrated that a 24-week mobile app–based human coaching program is beneficial for controlling body weight, BMI, triglyceride, and body composition in terms of bioimpedance for breast cancer survivors who are excessively overweight or have obesity.
- 24 September 2025
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 13 (1) , e64846
Open AccessImpact of a 24-Week Mobile App–Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort Study
Background: Overweight or obesity is a prognostic factor for breast cancer recurrence and breast cancer–related deaths. However, weight control is difficult for breast cancer survivors because of menopause, chemotherapy, antihormonal therapy, and psychological issues. Objective: This study aimed to develop a 24-week mobile app–based human coaching program using Noom and evaluate its efficacy in breast cancer survivors who are excessively overweight or with obesity, including those who successfully used the program. Methods: In this single-arm prospective cohort study, 130 breast cancer survivors with BMI ≥25 were enrolled and received a 24-week program, including diet-, exercise-, and psychology-based content with the trained human coach in Noom between 2019 and 2021. For a hyperactive group who joined for more than 16 weeks, we evaluated weight, BMI, lipid level, bioimpedance, and quality of life at baseline, 6-month, and 12-month follow-up. Results: Among 130 breast cancer survivors, 101 (77.7%) and 93 (71.5%) completed the 6-month and 12-month follow-ups, respectively. The mean age of all participants was 54.90 (SD 7.42) years. At baseline, the median BMI was 27.14 (IQR 25.20‐35.36) for the hyperactive group and 27.50 (IQR 25.20‐35.50) for the active and inactive group. In the hyperactive group (68/101, 67%), body weight and BMI significantly reduced (mean difference −1.97, 95% CI −2.65 to −1.26 kg; P<.01 and mean difference −0.86, 95% CI −1.15 to −0.56; P<.01, respectively) at 6 months and were maintained at 12 months without the yo-yo effect. Among the lipid panel, triglyceride levels decreased significantly (−34.13, 95% CI −58.09 to−10.17; P<.01) and were maintained at 12 months. With respect to bioimpedance components, skeletal muscle mass (kg), body fat mass (kg), percent body fat (%), waist-to-hip ratio, and visceral fat area (cm2) improved in the first 6 months. However, waist-to-hip ratio and visceral fat area increased during the next 6 months. Based on the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ C30) and Breast Cancer Module (23 items), nausea or vomiting, constipation, body image, and arm and breast symptoms significantly improved during the first 6 months. Conclusions: This study demonstrated that a 24-week mobile app–based human coaching program is beneficial for controlling body weight, BMI, triglyceride, and body composition in terms of bioimpedance for breast cancer survivors who are excessively overweight or have obesity.
- Open Access
- 20 April 2025
- Published by Korean Society of Gastrointestinal Cancer Research in Journal of Digestive Cancer Research
- Vol. 13 (1) , 74-81
Cancer Patient’s Distress: Mainly about Depression and Anxiety
Hyun Jeong Lee. Journal of Digestive Cancer Research 2025;13:74-81. https://doi.org/10.52927/jdcr.2025.13.1.74
- 20 April 2025
- Published by Korean Society of Gastrointestinal Cancer Research in Journal of Digestive Cancer Research
- Vol. 13 (1) , 74-81
Open AccessCancer Patient’s Distress: Mainly about Depression and Anxiety
Hyun Jeong Lee. Journal of Digestive Cancer Research 2025;13:74-81. https://doi.org/10.52927/jdcr.2025.13.1.74
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (31) , e226
Psychotropic Medications Promote Time-Dependent Reduction of Suicidal Ideation in Mood Disorder: A Prospective Cohort Study
Yang JH, et al. J Korean Med Sci. 2024 Jul;39:e226. https://doi.org/10.3346/jkms.2024.39.e226
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (31) , e226
Open AccessPsychotropic Medications Promote Time-Dependent Reduction of Suicidal Ideation in Mood Disorder: A Prospective Cohort Study
Yang JH, et al. J Korean Med Sci. 2024 Jul;39:e226. https://doi.org/10.3346/jkms.2024.39.e226
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Korean Medical Science
- Vol. 36 (5) , e39
Self-Transcendence Mediates the Relationship between Early Trauma and Fatal Methods of Suicide Attempts
Yang JH, et al. J Korean Med Sci. 2021 Jan;36(5):e39. https://doi.org/10.3346/jkms.2021.36.e39
- 1 January 2021
- Published by XMLink in Journal of Korean Medical Science
- Vol. 36 (5) , e39
Open AccessSelf-Transcendence Mediates the Relationship between Early Trauma and Fatal Methods of Suicide Attempts
Yang JH, et al. J Korean Med Sci. 2021 Jan;36(5):e39. https://doi.org/10.3346/jkms.2021.36.e39
- Open Access
- 13 January 2020
- Published by JMIR Publications Inc. in JMIR Formative Research
App-based CBT Program for Patients with Cancer Who Have Sleep-related Problems: A pilot study (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Cancer, as a chronic disease, develops secondary psychological and social difficulties of which one of the most common is sleep problems. Objective: The objective of this study was to develop and evaluate an app-based cognitive behavioral therapy program for cancer patients with sleep problems. Methods: Sixty participants who met the inclusion criteria were randomly assigned to the app-based cognitive behavioral therapy program (HARUToday Sleep) (N = 15), an app-based attentional control program (HARUCard Sleep) (N = 15), or a waitlist control group (N = 15). HARUToday Sleep consists of 48 sessions separated into five zones (psycho-education, behavioral activation, relaxation training, cognitive restructuring, and problem-solving). Each participant was required to complete one 10- to 15-minute session per day on weekdays for 10 weeks. In the HARUCard Sleep, participants received one card per day, which provided information about cancer, hobbies, and activities. Participants were evaluated before and after the completion of the program using self-report questionnaires and a dot-probe computer task that measured attentional bias. Results: The intensity of sleep problems decreased significantly after the intervention for the HARUToday Sleep group compared to the other two groups, whereas there were no significant changes in the quality of life score and the attentional bias scores of the patients. Conclusions: The HARUToday Sleep app may be an effective intervention for reducing sleep problems in cancer patients. Clinical Trial: ISRCTN study ID ISRCTN11480833 http://www.isrctn.com/ISRCTN11480833
- 13 January 2020
- Published by JMIR Publications Inc. in JMIR Formative Research
Open AccessApp-based CBT Program for Patients with Cancer Who Have Sleep-related Problems: A pilot study (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Cancer, as a chronic disease, develops secondary psychological and social difficulties of which one of the most common is sleep problems. Objective: The objective of this study was to develop and evaluate an app-based cognitive behavioral therapy program for cancer patients with sleep problems. Methods: Sixty participants who met the inclusion criteria were randomly assigned to the app-based cognitive behavioral therapy program (HARUToday Sleep) (N = 15), an app-based attentional control program (HARUCard Sleep) (N = 15), or a waitlist control group (N = 15). HARUToday Sleep consists of 48 sessions separated into five zones (psycho-education, behavioral activation, relaxation training, cognitive restructuring, and problem-solving). Each participant was required to complete one 10- to 15-minute session per day on weekdays for 10 weeks. In the HARUCard Sleep, participants received one card per day, which provided information about cancer, hobbies, and activities. Participants were evaluated before and after the completion of the program using self-report questionnaires and a dot-probe computer task that measured attentional bias. Results: The intensity of sleep problems decreased significantly after the intervention for the HARUToday Sleep group compared to the other two groups, whereas there were no significant changes in the quality of life score and the attentional bias scores of the patients. Conclusions: The HARUToday Sleep app may be an effective intervention for reducing sleep problems in cancer patients. Clinical Trial: ISRCTN study ID ISRCTN11480833 http://www.isrctn.com/ISRCTN11480833